Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing real-world reappraisal of cefuroxime axetil dispersible tablets
ChiCTR-OPN-17010365Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cefuroxime axetil in bacterial disease, sponsored by Peking Union Medical College Hospital. Primary endpoint: Bacterial clearance rate. Started Jan 2017; status: recruiting.
02
Drugs
cefuroxime axetil
03
Conditions
bacterial disease
Beyond the preview
Go deeper on ChiCTR-OPN-17010365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-17010365.